Charles J Homcy - Net Worth and Insider Trading
Charles J Homcy Net Worth
The estimated net worth of Charles J Homcy is at least $44 Million dollars as of 2024-05-12. Charles J Homcy is the Chairman of Pharmaceuticals of BridgeBio Pharma Inc and owns about 1,203,767 shares of BridgeBio Pharma Inc (BBIO) stock worth over $35 Million. Charles J Homcy is the Director of Global Blood Therapeutics Inc and owns about 69,328 shares of Global Blood Therapeutics Inc (GBT) stock worth over $5 Million. Charles J Homcy is also the Director of Portola Pharmaceuticals Inc and owns about 251,951 shares of Portola Pharmaceuticals Inc (PTLA) stock worth over $5 Million. Details can be seen in Charles J Homcy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles J Homcy has not made any transactions after 2020-10-16 and currently still holds the listed stock(s).
Transaction Summary of Charles J Homcy
Charles J Homcy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles J Homcy owns 9 companies in total, including BridgeBio Pharma Inc (BBIO) , Pliant Therapeutics Inc (PLRX) , and Portola Pharmaceuticals Inc (PTLA) among others .
Click here to see the complete history of Charles J Homcy’s form 4 insider trades.
Insider Ownership Summary of Charles J Homcy
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BBIO | BridgeBio Pharma Inc | 2020-10-16 | director & Chairman of Pharmaceuticals |
PLRX | Pliant Therapeutics Inc | 2020-06-02 | director |
PTLA | Portola Pharmaceuticals Inc | 2019-03-28 | other: Former Director |
2017-10-27 | director | ||
2016-11-29 | director | ||
2005-07-15 | director | ||
2005-05-19 | director | ||
2020-11-17 | director | ||
2020-11-17 | director |
Charles J Homcy Latest Holdings Summary
Charles J Homcy currently owns a total of 3 stocks. Among these stocks, Charles J Homcy owns 1,203,767 shares of BridgeBio Pharma Inc (BBIO) as of October 16, 2020, with a value of $35 Million and a weighting of 79.04%. Charles J Homcy owns 69,328 shares of Global Blood Therapeutics Inc (GBT) as of October 27, 2017, with a value of $5 Million and a weighting of 10.71%. Charles J Homcy also owns 251,951 shares of Portola Pharmaceuticals Inc (PTLA) as of December 17, 2018, with a value of $5 Million and a weighting of 10.25%.
Latest Holdings of Charles J Homcy
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BBIO | BridgeBio Pharma Inc | 2020-10-16 | 1,203,767 | 29.10 | 35,029,620 |
GBT | Global Blood Therapeutics Inc | 2017-10-27 | 69,328 | 68.49 | 4,748,275 |
PTLA | Portola Pharmaceuticals Inc | 2018-12-17 | 251,951 | 18.03 | 4,542,677 |
Holding Weightings of Charles J Homcy
Charles J Homcy Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles J Homcy has made a total of 5 transactions in BridgeBio Pharma Inc (BBIO) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in BridgeBio Pharma Inc is the sale of 10,256 shares on October 16, 2020, which brought Charles J Homcy around $420,496.
According to the SEC Form 4 filings, Charles J Homcy has made a total of 0 transactions in Global Blood Therapeutics Inc (GBT) over the past 5 years. The most-recent trade in Global Blood Therapeutics Inc is the sale of 70,000 shares on October 27, 2017, which brought Charles J Homcy around $2 Million.
According to the SEC Form 4 filings, Charles J Homcy has made a total of 0 transactions in Portola Pharmaceuticals Inc (PTLA) over the past 5 years. The most-recent trade in Portola Pharmaceuticals Inc is the sale of 64,218 shares on December 17, 2018, which brought Charles J Homcy around $1 Million.
Insider Trading History of Charles J Homcy
- 1
Charles J Homcy Trading Performance
Charles J Homcy Ownership Network
Ownership Network List of Charles J Homcy
Ownership Network Relation of Charles J Homcy
Charles J Homcy Owned Company Details
What does BridgeBio Pharma Inc do?
Who are the key executives at BridgeBio Pharma Inc?
Charles J Homcy is the director & Chairman of Pharmaceuticals of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include Chairman of Oncology Frank Mccormick , director & See Remarks Neil Kumar , and See Remarks Brian C Stephenson .
BridgeBio Pharma Inc (BBIO) Insider Trades Summary
Over the past 18 months, Charles J Homcy made no insider transaction in BridgeBio Pharma Inc (BBIO). Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 1,034,094 shares made by Neil Kumar , a net sale of 412,388 shares made by Brian C Stephenson , and a net sale of 9,500 shares made by Randal W Scott .
In summary, during the past 3 months, insiders sold 2,500 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 2,500 shares. During the past 18 months, 3,064,727 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,064,727 shares.
BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
BridgeBio Pharma Inc Insider Transactions
Charles J Homcy Mailing Address
Above is the net worth, insider trading, and ownership report for Charles J Homcy. You might contact Charles J Homcy via mailing address: Portola Pharmaceuticals, Inc., 270 East Grand Avenue, South San Francisco Ca 94080.